(1)
Myocardial Salvaging Effects and Mechanisms of Dipeptidyl Peptidase-IV Inhibitor Vildagliptin in Experimental Diabetes. Int Jour of Biomed Res 2016, 7 (5), 276-282. https://doi.org/10.7439/ijbr.v7i5.3273.